Emerging Market Investing26 Prices may fluctuate and you may not get back your original investment....

Preview:

Citation preview

Emerging Market Investing

January 2012

Michael Godfrey and Matthew Vaight, Co-fund managers

2

Agenda

• Why emerging markets matter

• What matters for emerging market investors

• Valuations

3

Why emerging markets matter Overview

Source: IMF, MSCI, Goldman Sachs Global ECS Research estimates, ML Calculations, BP, CIA World Factbook, IMF, MSCI as at 31 December 2010.

Emerging Market potential…

… not recognised by the market

PopulationLand Mass

FXReserves

GDPFull Market

CapMSCI AC

World

87% 81%

66%

37%

31%

13%

4

Many emerging market economies are relatively closed.

Domestic demand already a big driver of their economies.

Source: JPMorgan Economics, as at 31 Mar 11

Not just a global growth story

Why emerging markets matter

Total exports as % of GDP

0.0

20.0

40.0

60.0

80.0

100.0

120.0

5

0.0

10.0

20.0

30.0

40.0

50.0

60.0

70.0

Emerging market exports to the US and EU (% of GDP) by region

Why emerging markets matter US and Europe weakness is not material

Source: JPMorgan Economics, as at 31 Mar 11

6

World class companies

7

Agenda

• Why emerging markets matter

• What matters for emerging market investors

• Valuations

8 Source: HSBC as at June 2011

Economic growth has delivered lower shareholder returns Focus on what matters

Growth does not always create value

9

0

1

2

3

4

5

Average holding period (years)

Market inefficiencies are best exploited by disciplined

stock selection

Source: World Federation of Exchanges, as at 31 December 2010. *M&G projected holding period for the M&G Asian Fund and M&G Global Emerging Markets Fund

Investing vs speculating Short-term nature of emerging market investors creates opportunities

10

“Made in…….” A history of low cost manufacturing

11

“Made in…….” A history of low cost manufacturing

12

“Made in…….” A history of low cost manufacturing

13

“Made in…….” A history of low cost manufacturing

14

Case study: Mindray Medical

0%

10%

20%

30%

40%

50%

60%

70%

YoY increase in R&D

Source: Credit Suisse HOLT as at December 2011. © 2011 Credit Suisse and its subsidiaries and affiliates. Used by permission. All rights reserved.

CFROI® is a registered trademark of Credit Suisse or its affiliates in the United States and other countries

“Made in…….”

15

Corporate governance

16

Corporate governance

0

10

20

30

40

50

60

70

80

China Russia Brazil Taiwan India SouthAfrica

Mexico

MSCI country indices -% of index under state control

State influence

Source: Deutsche Bank, June 2011

17

Corporate governance Case Study: Gazprom Vs. Vale

• Russian oil and gas major

• Largest natural gas co in the world

• 50 % owned by Russian government

• Brazilian miner

• 2nd largest mining co in the world

• Golden share held by the government

18

Corporate governance

0.0

2.0

4.0

6.0

8.0

10.0

12.0

14.0

16.0

18.0

20.0

Gazprom Vale

Return on Capital (%)

Case Study: Gazprom vs. Vale

Source: Credit Suisse HOLT as at 30 November 2011. © 2011 Credit Suisse and its subsidiaries and affiliates. Used by permission. All rights reserved.

CFROI® is a registered trademark of Credit Suisse or its affiliates in the United States and other countries.

Cost of

Capital

19

The importance of valuations

Emerging market investors often overpay for growth.

However, markets reflect fundamentals over time.

Source: SG Equity Research as at September 2008, (1985-2007, % p.a.)

‘Value’ works in emerging markets

0

5

10

15

20

25

Growth Value

Emerging markets: returns across quintiles of value

20

Agenda

• Why emerging markets matter

• What matters for emerging market investors

• Valuations

21

Relative Performance

Source: Bloomberg, 31 December 2001 to 20 December 2011. Standard deviation and risk adjusted return calculated for the period.

Is such outperformance sustainable ?

A ‘lost decade’ for developed markets

0

50

100

150

200

250

300

350

400

450

Ind

exe

d t

o 1

00

MSCI World MSCI Emerging Markets

22

Valuations

0.0x

0.5x

1.0x

1.5x

2.0x

2.5x

3.0x

3.5x

4.0x

4.5x

19

92

19

93

19

94

19

95

19

96

19

97

19

98

19

99

20

00

20

01

20

02

20

03

20

04

20

05

20

06

20

07

20

08

20

09

20

10

20

11

MSCI EM MSCI World

3.0

5.0

7.0

9.0

11.0

13.0

15.0

17.0

19.0

19

92

19

93

19

94

19

95

19

96

19

97

19

98

19

99

20

00

20

01

20

02

20

03

20

04

20

05

20

06

20

07

20

08

20

09

20

10

20

11

MSCI EM MSCI World

%

Source: Morgan Stanley 22 November 2011

Emerging markets are attractive given high returns

Trailing Price to Book Value Trailing Return on Equity

23

Emerging markets Conclusions

Valuations ?

Valuations are

attractive given

fundamentals

Why invest ?

Companies

increasingly focused

on value creation

How we invest ?

Backing companies

we trust over the

long term

24

An S&P Fund Management Rating represents an opinion only and should not be relied on when making an investment decision.

“S&P” and “Standard & Poor’s” are trademarks of The McGraw-Hill Companies, Inc. Copyright 2010 © Standard & Poor’s Financial Services LLC.

Source: M&G, Morningstar as at 30 November 2011. Ratings as at 30 November 2011 and should not be taken as a recommendation

Co-fund managers: Michael Godfrey and Matthew Vaight

Fund Launch: February 2009

Fund size: £548 million

Benchmark: MSCI Emerging Markets

Style: Bottom-up stockpicking

Number of stocks: 50 - 70

M&G Global Emerging Markets Fund Fund facts

25

M&G Global Emerging Markets Fund Performance since launch*

Source: Morningstar as at 16 December 2011, Sterling A class shares, bid to bid, net income reinvested * The fund was launched in February 2009

80

100

120

140

160

180

200

220

240

M&G Global Emerging Markets Fund MSCI EM Mstar (IMA) Global Emg Mkts

Ind

exe

d to

10

0

26

Prices may fluctuate and you may not get back your original investment.

For Financial Advisers only. Not for onward distribution. No other persons should rely on any information contained within. This Financial Promotion is issued by M&G

Securities Limited which is authorised and regulated by the Financial Services Authority and provides investment products. The registered office is Laurence Pountney Hill, London, EC4R

0HH. Registered in England No. 90776